Company overview

SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company dedicated to improving the lives of patients with rare tumors. We developed and are commercializing the first and only FDA and EC approved medicine for adults with desmoid tumors and the first and only FDA and EC approved medicine for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN). At SpringWorks, we are committed to finding answers people with rare tumors need. We thrive in an atmosphere of passion and tenacity, fueled by the excitement of the possibilities science may unlock and driven to work with urgency because of the importance of our work. We value authenticity because diverse backgrounds, cultures, styles and abilities can only help us find the answers that people with rare tumors are looking for.
Founded in 2017
Stamford, Connecticut, USA
420 employees (27 in marketing)
73% recommend to a friend
82% positive business outlook

Salaries

Typical salary range

$165,000 – $230,000

/ yr

Help build salary transparency at SpringWorks Therapeutics

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

5 open now

Headcount trend

Company growth over the last 12 months

Headcount +9.6% year over year

Funding

Total funding

$1B

Last raise

$275M

Post IPO Equity, 2 years ago

Funding history

Dec 2023

Post IPO Equity SpringWorks Therapeutics · $275M

Sep 2022

Post IPO Equity SpringWorks Therapeutics · $225M

Oct 2020

Post IPO Equity SpringWorks Therapeutics · $287.5M

Apr 2019

Series B SpringWorks Therapeutics · $125M

Sep 2017

Series A SpringWorks Therapeutics · $103M

Audience

Monthly website visitors
11.9K
Month over month-42.9%
Quarter over quarter+2.9%
Top sourceSearch (49.8%)
Ad budget per month$0.0
Average search rank43.2
Traffic source mix
Search
49.8%
Direct
38%
Referral
6%
Social
4.8%
Paid referral
1.3%

LinkedIn followers

Follower count and growth

Total followers

29.6K

12-mo growth

+42.7%

Monthly growth

+1.3%

News

Links